Nutex Health Management
Management criteria checks 2/4
Nutex Health's CEO is Tom Vo, appointed in Apr 2022, has a tenure of 2.67 years. total yearly compensation is $1.01M, comprised of 98.6% salary and 1.4% bonuses, including company stock and options. directly owns 33.64% of the company’s shares, worth $58.25M. The average tenure of the management team and the board of directors is 2.7 years and 2.7 years respectively.
Key information
Tom Vo
Chief executive officer
US$1.0m
Total compensation
| CEO salary percentage | 98.6% |
| CEO tenure | 2.7yrs |
| CEO ownership | 33.6% |
| Management average tenure | 2.7yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Health Check: How Prudently Does Nutex Health (NASDAQ:NUTX) Use Debt?
Jan 24
Nutex Health Inc. (NASDAQ:NUTX) Might Not Be As Mispriced As It Looks
Dec 25Nutex Health Inc. (NASDAQ:NUTX) Just Reported, And Analysts Assigned A US$2.75 Price Target
Aug 12Nutex Health Inc.'s (NASDAQ:NUTX) 30% Cheaper Price Remains In Tune With Revenues
Apr 17Nutex Health GAAP EPS of -$0.03, revenue of $58.05M
Aug 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$41m |
| Jun 30 2024 | n/a | n/a | -US$38m |
| Mar 31 2024 | n/a | n/a | -US$41m |
| Dec 31 2023 | US$1m | US$992k | -US$46m |
| Sep 30 2023 | n/a | n/a | -US$29m |
| Jun 30 2023 | n/a | n/a | -US$436m |
| Mar 31 2023 | n/a | n/a | -US$451m |
| Dec 31 2022 | US$938k | US$932k | -US$425m |
| Sep 30 2022 | n/a | n/a | -US$396m |
| Jun 30 2022 | n/a | n/a | US$70m |
| Mar 31 2022 | n/a | n/a | US$122m |
| Dec 31 2021 | US$258k | US$251k | US$133m |
| Sep 30 2021 | n/a | n/a | US$159m |
| Dec 31 2020 | US$159k | US$151k | US$106m |
Compensation vs Market: Tom's total compensation ($USD1.01M) is about average for companies of similar size in the US market ($USD1.38M).
Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.
CEO
Tom Vo (51 yo)
2.7yrs
Tenure
US$1,005,711
Compensation
Dr. Thomas T. Vo, M.D., MBA, also known as Tom, is Chairman of the Board and CEO of Nutex Health, Inc. from April 1, 2022. Dr. Vo joined the Nutex Health, Inc. in April 1, 2022. Thomas T. Vo, MD. has since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 2.7yrs | US$1.01m | 33.64% $ 58.2m | |
| President & Director | 2.7yrs | US$734.39k | 0.013% $ 22.9k | |
| Chief Financial Officer | 2.5yrs | US$453.71k | 0.042% $ 72.5k | |
| Chief Operating Officer | 1.3yrs | no data | 0.088% $ 153.1k | |
| Director of Accounting | no data | no data | no data | |
| Director of Compliance | 1.4yrs | no data | no data | |
| Director of Marketing | no data | no data | no data | |
| Director of Human Resources | 2.9yrs | no data | no data | |
| Chief Medical Officer | 2.7yrs | no data | 1.47% $ 2.5m | |
| Chief Legal Officer of Healthcare & Board Secretary | no data | US$275.36k | 0.0055% $ 9.6k | |
| Chief Legal Officer of SEC & Board Secretary | 2.7yrs | US$593.32k | 0.0016% $ 2.7k | |
| Controller | no data | no data | no data |
2.7yrs
Average Tenure
53.5yo
Average Age
Experienced Management: NUTX's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 2.7yrs | US$1.01m | 33.64% $ 58.2m | |
| President & Director | 2.7yrs | US$734.39k | 0.013% $ 22.9k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 2.7yrs | US$144.38k | 0.010% $ 17.4k | |
| Independent Director | 2.7yrs | US$144.38k | no data | |
| Independent Director | 2.7yrs | US$131.25k | 0.0012% $ 2.1k | |
| Director | less than a year | no data | 0.59% $ 1.0m |
2.7yrs
Average Tenure
63yo
Average Age
Experienced Board: NUTX's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 04:08 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nutex Health Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Sutherland | Benchmark Company |
| Eugene Mannheimer | Freedom Capital Markets |
| Anthony Vendetti | Maxim Group |